Column Group L P
- SEC CIK
- 0001347769
No open-market purchases or sales filed in the past year.
Current role at each company
- NGM NGM Biopharmaceuticals IncDirector, 10% Owneras of Apr 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Column Group L P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2022 (view filing)5:30 PM ET | May 11-12 | 2 days | Column Group L P and 9 othersDirector, 10% Owner | PPurchase | +166.3K | $11.43 | +$1.90M | New position37.3K after | 8 lots |
| May 11, 2022 (view filing)6:14 PM ET | May 9-10 | 2 days | Column Group L P and 7 othersDirector, 10% Owner | PPurchase | +114.4K | $10.95 | +$1.25M | New position31.8K after | 4 lotsDuplicate filing |
| May 11, 2022 (view filing)6:03 PM ET | May 9-10 | 2 days | Column Group L P and 9 othersDirector, 10% Owner | PPurchase | +114.4K | $10.95 | +$1.25M | New position31.8K after | 4 lots |
| Jan 26, 2022 (view filing)7:14 PM ET | Jan 24-25 | 2 days | Column Group L P and 7 othersDirector, 10% Owner | PPurchase | +849.7K | – | – | New position28.0K after | 4 lotsDuplicate filing |
| Jan 26, 2022 (view filing)7:12 PM ET | Jan 24-25 | 2 days | Column Group L P and 9 othersDirector, 10% Owner | PPurchase | +849.7K | – | – | New position28.0K after | 4 lotsDuplicate filing |